Skip to content

Devyser CVD

In vitro diagnostic kit for the qualitative detection of genetic risk factors for the development of cardiovascular disease (CVD).

7

Detects seven risk factors for cardiovascular disease

Test tube icon

Single-tube PCR

45

Fast analysis with minimum hands-on time

Product information

Genetic risk factors for CVD

Atherosclerosis and venous thrombosis are two major manifestations of CVD. Both can be caused by complex interactions of environmental and genetic factors. An unhealthy lifestyle in combination with genetic risk factors can contribute to the occurrence of CVD. Similarly, a combination of adverse influences (female hormone intake, immobilization, surgery or cancer) and variations in genes responsible for the coagulation system can contribute to CVD. Testing for genetic risk factors can therefore be a powerful tool for guidance to a lifestyle that is in accordance with an individual’s genetic predisposition.

Devyser CVD

The Devyser CVD kit offers a very simple procedure for identification of mutations and polymorphisms implicated as genetic risk factors for the development of CVD. It is a multiplex PCR reagent kit for simultaneous detection of seven genetic risk factors associated with CVD:

Downloads

Instructions for use

Enter access code found in the lower right corner of the label on the kit box.

product card

Certificates

Download a specific Batch Release Certificate (BRC) below.

Guidelines and handbooks (4)

Data Analysis Using GeneMapper 2018-12-10 (English)

pdf

Devyser CVD Handbook 7-A124 AA 01 (English) (English)

436 kb pdf

Addendum to handbook Devyser SeqStudio allele-specific products 7-B908 v2023-03-30 (English)

489 kb pdf

Addendum to handbook Devyser VeritiPro allele-specific products 7-B906 v2023-03-31 (English)

82 kb pdf

Product information (2)

Flyer: Devyser CVD (English)

pdf

Flyer: Devyser CVD (Italian)

pdf

Software settings (7)

GeneMapper Settings Devyser CVD_GM4-5_2018-01-10 (English)

zip

Fragment Analysis Using ABI PRISM 310_2020-06-15 (English)

pdf

Fragment Analysis Using ABI 3730 & 3730xL 2020-06-15 (English)

pdf

Fragment Analysis Using ABI 3130 & 3130xL 2020-06-15 (English)

pdf

Fragment Analysis Using ABI 3500 & 3500xL 2020-06-15, c2021-01-19 (English)

pdf

Fragment analysis using SeqStudio v2023-02-13 (English)

pdf

Devyser Seqstudio Settings v.2022-12-29 (English)

4 kb

Safety data sheets (1)

SDS Devyser FA products 7-A429 v2024-01-10 (English)

569 kb pdf

Data tables (0)

Enter access code found in the lower right corner of the label on the kit box.

product card

Product details

CE-IVD

Devyser CVD

Detection of the following SNPs and their corresponding normal alleles: Factor XIII: V34L (rs5985); Fibrinogen Beta Chain (FGB): c.-463G>A (rs1800790); Human Platelet Antigen 1 (HPA-1a/HPA-1b)/Platelet receptor GPIIIa/(ITGB3): L59P/c.176T>C (rs5918); Angiotensin Converting Enzyme (ACE): 287bp gene deletion/insertion (rs1799752); Angiotensin/ Angiotensinogen (AGT): M268T (rs699); Angiotensin II type 1 receptor (AGTR1): c.*86A>C (rs5186); Cystathionine Beta-Synthase (CBS): 844ins68

8-A036

Pack size: 48

RUO

Devyser CVD

Detection of the following SNPs and their corresponding normal alleles: Factor XIII: V34L (rs5985); Fibrinogen Beta Chain (FGB): c.-463G>A (rs1800790); Human Platelet Antigen 1 (HPA-1a/HPA-1b)/Platelet receptor GPIIIa/(ITGB3): L59P/c.176T>C (rs5918); Angiotensin Converting Enzyme (ACE): 287bp gene deletion/insertion (rs1799752); Angiotensin/ Angiotensinogen (AGT): M268T (rs699); Angiotensin II type 1 receptor (AGTR1): c.*86A>C (rs5186); Cystathionine Beta-Synthase (CBS): 844ins68

8-A036-RUO

Pack size: 48

Ask us

Want to know more about Devyser CVD or do you have any questions?

Complete the form below and we will be in touch promptly.

smiling-staff-member

Related Devyser blog posts

View all

Data analysis made easy

Fast and effective test data analysis is crucial to achieving accurate outcomes and efficient workflows.

Dedicated software in our products makes analyzing test results quick, easy and trouble-free. For users, this means a streamlined end-to-end process with unmatched reliability and transparency.

Find out more

"
testimonial